Updated

Scientists have discovered that overactive immune cells in the brain drive sleep loss in Alzheimer's disease, and by temporarily removing these cells in mice they restored more than two hours of sleep per day. The finding reveals a new therapeutic target for treating sleep disruption in Alzheimer's patients and could lead to treatments that modulate immune function rather than attempting to clear brain plaques.